Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$182.66 - $235.53 $3.54 Million - $4.56 Million
19,365 Added 34.13%
76,103 $15.2 Million
Q4 2022

Feb 14, 2023

BUY
$185.53 - $241.31 $3.92 Million - $5.1 Million
21,125 Added 59.32%
56,738 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$138.54 - $232.0 $1.45 Million - $2.43 Million
-10,491 Reduced 22.76%
35,613 $7.13 Million
Q2 2022

Aug 15, 2022

SELL
$120.42 - $169.29 $4.45 Million - $6.25 Million
-36,934 Reduced 44.48%
46,104 $6.72 Million
Q1 2022

May 16, 2022

BUY
$127.18 - $173.91 $10.6 Million - $14.4 Million
83,038 New
83,038 $13.6 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.